started · updated
South Korean biotech industry seeks global expansion at international forums
South Korean pharmaceutical and biotech entities are actively pursuing international partnerships and market expansion through major industry events. At BioPlus-Interphex Korea 2026, the Hwasun Chonnam National University Hospital Advanced Precision Medical Industry Support Center facilitated over 100 consultations for regional biotech firms, including NPK Bio, Kablu Bio, and VS Pharmtech, focusing on manufacturing, distribution, and investment.
Simultaneously, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) participated in BioEurope 2026 in Cologne, Germany. The association engaged with international organizations, such as the U.S. Biotechnology Innovation Organization (BIO), to discuss business matching and regulatory cooperation. During the event, approximately 210 South Korean companies participated, making Korea the fourth largest national delegation. Support activities included the Korea Pavilion, corporate IR sessions, and the Korea Night reception, which saw a record 36% international attendance.
Entities
BioEurope 2026 · Biotechnology Innovation Organization · Hwasun Chonnam National University Hospital · Korea Pharmaceutical and Bio-Pharma Manufacturers Association · South Korea